학술논문
Initial results from a first-in-human, phase I study of immunomodulatory aryl hydrocarbon receptor (AhR) inhibitor BAY2416964 in patients with advanced solid tumors.
Document Type
Article
Author
Dumbrava, Ecaterina Elena; Cecchini, Michael; Zugazagoitia, Jon; Lopez, Juanita Suzanne; Jäger, Dirk; Oliva, Marc; Ochsenreither, Sebastian; Gambardella, Valentina; Chung, Ki Y.; Longo, Federico; Abdul Razak, Albiruni Ryan; Wermke, Martin; Evans, T.R. Jeffry; Cook, Natalie; Chenard-Poirier, Maxime; Pencheva, Radost; Schaer, David; Wagener, Thomas; Wagner, Andrea; Papadopoulos, Kyriakos P.
Source
Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p2502-2502, 1p
Subject
Language
ISSN
0732183X